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Aims & rationale
Many medicines prescribed in general practice require a dosage change as kidney
function routinely declines with aging. Presently there lacks a systematic approach
to identifying the patients at risk of a medication-related adverse event. The aim of
this preliminary research was to investigate how kidney function is assessed and the
appropriateness of use of medications in this general practice, in a population 65
years or older, by engaging a clinical pharmacist.
Methods
The first stage of the research was to retrospectively estimate the kidney function,
via the Cockcroft-Gault equation (used for drug-dosing) and compare this with the
measure of kidney function, the eGFR (estimated Glomerular Filtration Rate)
provided by laboratories, of the recruited patients. Medications known to require
attention when used in kidney impairment were recorded if used and their
appropriateness analysed.
Findings
The kidney function and medicines of 96 patients were assessed retrospectively.
The mean estimates of kidney function using the two assessments were statistically
significantly different (45mL/min vs 63mL/min/1.73m2, p<0.0001). Over half (56%) of
the patients had some degree of kidney impairment; 51 individual medicines that
require attention in kidney impairment were prescribed. The majority of usage was
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Background
Kidney function declines with age. Many medicines
require care when used in older people. GPs’ self1
reported errors and medication-related hospital
2
admissions suggest that management could be improved.
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Findings
Records of 96 patients were reviewed.
Kidney function:


All patients reviewed had kidney
function assessed;



CrCl was not estimated for patients
to guide drug-dosing;



cohort means of eGFR & estimated
CrCl were statistically significantly
different:

Estimates of kidney function
Known as:
Availability:

Glomerular filtration rate

Creatinine clearance

eGFR

eCRCl

Routinely reported by labs

Calculated using:
 medical software
 MDCalc©

Intended use:

Staging in kidney disease

Guides drug dosing

Clinical
significance:

eGFR <60mL/minute/1.73m2
- marker of CKD (stage 3a)

Reduce drug dose/ precautions with:
 some medicines if < 60mL/min
 many medicines if < 50mL/min

2

2

63mL/min/1.73m vs 45mL/min,
p<0.0001). See Figure.


Figure: Means of estimates of kidney function, from
reported eGFR and calculated creatinine clearance (using
ideal body weight) for patient cohort

Over half (56%) had reduced kidney
function requiring caution with medicines

Appropriateness of medicines:
64% of medicines used in patients with impaired kidney function were
managed appropriately for degree of kidney impairment



Stages of kidney impairment3

Why worry about kidney function?
Case 1 (from review)

How GPs can assess kidney
function:
Measure



eGFR

Estimated Glomerular
Filtration Rate



Intended use Staging in kidney
disease
Availability

Aim

Routinely reported by
laboratories



85 year-old female; medical history of hypertension,
osteoarthritis, vascular disease, haematuria, osteopenia, atrial
fibrillation and history of stroke



Commenced dabigatran 150mg (an anticoagulant) twice daily;
to reduce her risk of stroke.



Admitted to hospital with upper GIT haemorrhage.

eCrCl calculated using
eCrCl
Estimated
Creatinine
Best
Practice™
clinical tools

2

Clearance



eGFR 31 – 42 mL/min/ 1.73m ; eCrCl 23- 30mL/min.

Drug dosing



Dabigatran contraindicated

reported eGFR

Case 2 (from review)

Calculated
Best Practice™ medical
software AND



88 year old female; medical history of diabetes,
heart failure, polymyalgia rheumatic; osteopenia



Commenced pregabalin 75mg twice daily
(neuropathic pain)



Confused, drowsy; two falls in 2 days.

In a population 65 years or older, to investigate:



how kidney function
Significance is assessed;
eGFR < 60mL/and

MDCalc
Reduce dose/ caution

min/1.73m2—stage 3
medspresence
CrCl< 60mL/ of
of use of medicationssome
in the
CKD
min

the appropriateness
reduced kidney function;



many meds <50mL/

in this general practice, by engaging a clinical pharmacist.

Methods



measures of kidney function (serum
creatinine, eGFR); and
medications that require caution in
reduced kidney function.

Estimates of kidney function were compared
and medicines were assessed for
appropriateness, based on current
recommendations for dosing and monitoring
when kidney function is reduced.
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eGFR 40mL/min/1.73m ; eCrCl 25mL/min



recommended dose 25- 50mg daily (⅓ dose given)

Target medicines

After consent, patients’ records were retrospectively reviewed by
the pharmacist, for 2 years for:
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From the analysis of appropriateness of medicines, GPs developed the list of TARGET
medicines; for “recall & review” of patients
Medicines and groups
anticoagulants (nonvitamin K antagonists)
antidiabetics*

apixaban (Eliquis™)
dabigatran (Pradaxa™)
rivaroxaban (Xarelto™)
gliclazide
“gliptins”
metformin

digoxin
statins

e.g. simvastatin 80mg

pregabalin

(Lyrica™)

Use with reduced kidney function
Lower dose or contra-indicated
Risk of low blood sugar
Targets relaxed for people with comorbidities
Low dose; risk of adverse effects
Monitor kidney function and potassium
Digoxin levels at 6 hours after last dose
Contra-indicated
Lower starting doses and maximum dose
Adverse effects+++

* newer antidiabetic agents (SGLT2 inhibitors) also require caution but were not used in this practice

Relevance to research and practice needs
Although the majority of medicines are managed appropriately, the engagement of
the pharmacist has helped identify medicines to target in this “high-risk” population.
Feedback, recall and review are underway to improve the quality use of these
medicines within this general practice.
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appropriate; medicines identified as requiring more attention included non-vitamin K
oral anticoagulants, pregabalin, digoxin, nitrofurantoin, simvastatin, metformin and
allopurinol.
Relevance to policy, research and/or practice needs
This general practice manages medicines in a high-risk population appropriately in
most instances. Following research will be to assess the implementation of practice
changes for kidney assessment and management of specific medicines.
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